The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Fusion Protein Therapy Market Research Report 2025

Global Fusion Protein Therapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1897146

No of Pages : 105

Ask Your Query
Synopsis
Fusion proteins or chimeric (kī-ˈmir-ik) proteins (literally, made of parts from different sources) are proteins created through the joining of two or more genes that originally coded for separate proteins. 
The global Fusion Protein Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Fusion Protein Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fusion Protein Therapy.
Report Scope
The Fusion Protein Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fusion Protein Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fusion Protein Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abnova
Novus
Origene
Chimerigen
Peprotech
Prospec
Aboslute Antibody
Amgen
Abbvie
J & J
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Biogen
UCB
Eli Lilly and Company
AstraZeneca
Segment by Type
Immunoglobulin (Ig) Fusion Protein
Parathyroid Hormone (PTH) Fusion Protein
Cytokines Recombinant Fusion Protein
Others
Segment by Application
Chimeric Protein Drugs
Biological Technology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fusion Protein Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fusion Protein Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunoglobulin (Ig) Fusion Protein
1.2.3 Parathyroid Hormone (PTH) Fusion Protein
1.2.4 Cytokines Recombinant Fusion Protein
1.2.5 Others
1.3 Market by Application
1.3.1 Global Fusion Protein Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Chimeric Protein Drugs
1.3.3 Biological Technology
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fusion Protein Therapy Market Perspective (2019-2030)
2.2 Fusion Protein Therapy Growth Trends by Region
2.2.1 Global Fusion Protein Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Fusion Protein Therapy Historic Market Size by Region (2019-2024)
2.2.3 Fusion Protein Therapy Forecasted Market Size by Region (2025-2030)
2.3 Fusion Protein Therapy Market Dynamics
2.3.1 Fusion Protein Therapy Industry Trends
2.3.2 Fusion Protein Therapy Market Drivers
2.3.3 Fusion Protein Therapy Market Challenges
2.3.4 Fusion Protein Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fusion Protein Therapy Players by Revenue
3.1.1 Global Top Fusion Protein Therapy Players by Revenue (2019-2024)
3.1.2 Global Fusion Protein Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Fusion Protein Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fusion Protein Therapy Revenue
3.4 Global Fusion Protein Therapy Market Concentration Ratio
3.4.1 Global Fusion Protein Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fusion Protein Therapy Revenue in 2023
3.5 Fusion Protein Therapy Key Players Head office and Area Served
3.6 Key Players Fusion Protein Therapy Product Solution and Service
3.7 Date of Enter into Fusion Protein Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fusion Protein Therapy Breakdown Data by Type
4.1 Global Fusion Protein Therapy Historic Market Size by Type (2019-2024)
4.2 Global Fusion Protein Therapy Forecasted Market Size by Type (2025-2030)
5 Fusion Protein Therapy Breakdown Data by Application
5.1 Global Fusion Protein Therapy Historic Market Size by Application (2019-2024)
5.2 Global Fusion Protein Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Fusion Protein Therapy Market Size (2019-2030)
6.2 North America Fusion Protein Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Fusion Protein Therapy Market Size by Country (2019-2024)
6.4 North America Fusion Protein Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fusion Protein Therapy Market Size (2019-2030)
7.2 Europe Fusion Protein Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Fusion Protein Therapy Market Size by Country (2019-2024)
7.4 Europe Fusion Protein Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fusion Protein Therapy Market Size (2019-2030)
8.2 Asia-Pacific Fusion Protein Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Fusion Protein Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Fusion Protein Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fusion Protein Therapy Market Size (2019-2030)
9.2 Latin America Fusion Protein Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Fusion Protein Therapy Market Size by Country (2019-2024)
9.4 Latin America Fusion Protein Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fusion Protein Therapy Market Size (2019-2030)
10.2 Middle East & Africa Fusion Protein Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Fusion Protein Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Fusion Protein Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Fusion Protein Therapy Introduction
11.1.4 Roche Revenue in Fusion Protein Therapy Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Abnova
11.2.1 Abnova Company Detail
11.2.2 Abnova Business Overview
11.2.3 Abnova Fusion Protein Therapy Introduction
11.2.4 Abnova Revenue in Fusion Protein Therapy Business (2019-2024)
11.2.5 Abnova Recent Development
11.3 Novus
11.3.1 Novus Company Detail
11.3.2 Novus Business Overview
11.3.3 Novus Fusion Protein Therapy Introduction
11.3.4 Novus Revenue in Fusion Protein Therapy Business (2019-2024)
11.3.5 Novus Recent Development
11.4 Origene
11.4.1 Origene Company Detail
11.4.2 Origene Business Overview
11.4.3 Origene Fusion Protein Therapy Introduction
11.4.4 Origene Revenue in Fusion Protein Therapy Business (2019-2024)
11.4.5 Origene Recent Development
11.5 Chimerigen
11.5.1 Chimerigen Company Detail
11.5.2 Chimerigen Business Overview
11.5.3 Chimerigen Fusion Protein Therapy Introduction
11.5.4 Chimerigen Revenue in Fusion Protein Therapy Business (2019-2024)
11.5.5 Chimerigen Recent Development
11.6 Peprotech
11.6.1 Peprotech Company Detail
11.6.2 Peprotech Business Overview
11.6.3 Peprotech Fusion Protein Therapy Introduction
11.6.4 Peprotech Revenue in Fusion Protein Therapy Business (2019-2024)
11.6.5 Peprotech Recent Development
11.7 Prospec
11.7.1 Prospec Company Detail
11.7.2 Prospec Business Overview
11.7.3 Prospec Fusion Protein Therapy Introduction
11.7.4 Prospec Revenue in Fusion Protein Therapy Business (2019-2024)
11.7.5 Prospec Recent Development
11.8 Aboslute Antibody
11.8.1 Aboslute Antibody Company Detail
11.8.2 Aboslute Antibody Business Overview
11.8.3 Aboslute Antibody Fusion Protein Therapy Introduction
11.8.4 Aboslute Antibody Revenue in Fusion Protein Therapy Business (2019-2024)
11.8.5 Aboslute Antibody Recent Development
11.9 Amgen
11.9.1 Amgen Company Detail
11.9.2 Amgen Business Overview
11.9.3 Amgen Fusion Protein Therapy Introduction
11.9.4 Amgen Revenue in Fusion Protein Therapy Business (2019-2024)
11.9.5 Amgen Recent Development
11.10 Abbvie
11.10.1 Abbvie Company Detail
11.10.2 Abbvie Business Overview
11.10.3 Abbvie Fusion Protein Therapy Introduction
11.10.4 Abbvie Revenue in Fusion Protein Therapy Business (2019-2024)
11.10.5 Abbvie Recent Development
11.11 J & J
11.11.1 J & J Company Detail
11.11.2 J & J Business Overview
11.11.3 J & J Fusion Protein Therapy Introduction
11.11.4 J & J Revenue in Fusion Protein Therapy Business (2019-2024)
11.11.5 J & J Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Detail
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Fusion Protein Therapy Introduction
11.12.4 Bristol-Myers Squibb Revenue in Fusion Protein Therapy Business (2019-2024)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 Novartis
11.13.1 Novartis Company Detail
11.13.2 Novartis Business Overview
11.13.3 Novartis Fusion Protein Therapy Introduction
11.13.4 Novartis Revenue in Fusion Protein Therapy Business (2019-2024)
11.13.5 Novartis Recent Development
11.14 Merck
11.14.1 Merck Company Detail
11.14.2 Merck Business Overview
11.14.3 Merck Fusion Protein Therapy Introduction
11.14.4 Merck Revenue in Fusion Protein Therapy Business (2019-2024)
11.14.5 Merck Recent Development
11.15 Alexion Pharmaceuticals
11.15.1 Alexion Pharmaceuticals Company Detail
11.15.2 Alexion Pharmaceuticals Business Overview
11.15.3 Alexion Pharmaceuticals Fusion Protein Therapy Introduction
11.15.4 Alexion Pharmaceuticals Revenue in Fusion Protein Therapy Business (2019-2024)
11.15.5 Alexion Pharmaceuticals Recent Development
11.16 Takeda
11.16.1 Takeda Company Detail
11.16.2 Takeda Business Overview
11.16.3 Takeda Fusion Protein Therapy Introduction
11.16.4 Takeda Revenue in Fusion Protein Therapy Business (2019-2024)
11.16.5 Takeda Recent Development
11.17 Biogen
11.17.1 Biogen Company Detail
11.17.2 Biogen Business Overview
11.17.3 Biogen Fusion Protein Therapy Introduction
11.17.4 Biogen Revenue in Fusion Protein Therapy Business (2019-2024)
11.17.5 Biogen Recent Development
11.18 UCB
11.18.1 UCB Company Detail
11.18.2 UCB Business Overview
11.18.3 UCB Fusion Protein Therapy Introduction
11.18.4 UCB Revenue in Fusion Protein Therapy Business (2019-2024)
11.18.5 UCB Recent Development
11.19 Eli Lilly and Company
11.19.1 Eli Lilly and Company Company Detail
11.19.2 Eli Lilly and Company Business Overview
11.19.3 Eli Lilly and Company Fusion Protein Therapy Introduction
11.19.4 Eli Lilly and Company Revenue in Fusion Protein Therapy Business (2019-2024)
11.19.5 Eli Lilly and Company Recent Development
11.20 AstraZeneca
11.20.1 AstraZeneca Company Detail
11.20.2 AstraZeneca Business Overview
11.20.3 AstraZeneca Fusion Protein Therapy Introduction
11.20.4 AstraZeneca Revenue in Fusion Protein Therapy Business (2019-2024)
11.20.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock